The story of Sildenafil presents a intricate picture for shareholders. While the initial introduction generated significant gains, the expiration of its patent opened the door to off-brand competitors, dramatically https://rajanjato020932.verybigblog.com/40586938/sildenafil-and-the-pharmaceutical-industry-a-precarious-investment